Medicover AB Stock: price and insider trades · Sweden

Medicover AB belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. The last twelve months, up to 18 October 2026, brought 17 filings signed by 11 insiders.

Both sides are active: 6 purchases worth €297k and 4 sales worth €4.1M, from 3 insiders and 3 insiders respectively. Sales outweigh purchases by €3.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 2 board members. One trade stands out by size: a sale of €2.1M from Fredrik Rågmark, disclosed on 12 August 2026, or 0.060% of market capitalisation.

Compared with its exchange (885 companies, median 7 filings), a count of 17 filings is above the norm. Over the whole record (from 2025), the tally stands at 6 purchases and 6 sales.

The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The latest purchase dates back some time: it was published 33 days ago, on 14 September 2026. Filings reach the Finansinspektionen feed a median of 2 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.